Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidation
- PMID: 16626676
- DOI: 10.1016/j.cca.2006.02.028
Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidation
Abstract
Background: Oxidative modification of low-density lipoprotein (LDL) is an important contributor to atherosclerosis. Also, oxidized LDL is suspected to cause accumulation of asymmetric dimethylarginine (ADMA), an endogenous competitive nitric oxide synthase inhibitor, which is suggested to be an independent risk factor for atherosclerosis. This study was performed to evaluate how plasma ADMA is related to plasma nitric oxide production, oxidized LDL and ex vivo susceptibility of LDL to oxidation in mildly hypercholesterolemic otherwise healthy subjects.
Methods: Plasma ADMA was determined using high performance liquid chromatography tandem mass spectrometry. LDL oxidation was estimated by the lag time and rate of copper-induced LDL oxidation. The nitric oxide production in plasma was estimated based on nitrate (NO(3)(-)) determination and plasma oxidized LDL was determined by a capture ELISA.
Results: Low ADMA was a significant determinant for high LDL oxidation rate and concentration of plasma ADMA was associated with nitrate levels.
Conclusions: There may be an interplay between LDL fatty acid oxidation rate and plasma ADMA and nitrate. We hypothesize that plasma ADMA has a bivalent role: high ADMA may have a protective role in decelerating LDL fatty acid oxidation and also a risk factor for endothelial dysfunction by decreasing availability of nitric oxide.
Similar articles
-
The issue of plasma asymmetric dimethylarginine reference range - A systematic review and meta-analysis.PLoS One. 2017 May 11;12(5):e0177493. doi: 10.1371/journal.pone.0177493. eCollection 2017. PLoS One. 2017. PMID: 28494019 Free PMC article. Review.
-
Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia.Clin Hemorheol Microcirc. 2014;57(4):315-23. doi: 10.3233/CH-131706. Clin Hemorheol Microcirc. 2014. PMID: 23455843
-
Determination of asymmetric dimethylarginine in biological fluids: a paradigm for a successful analytical story.Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):592-600. doi: 10.1097/MCO.0b013e3283065bb1. Curr Opin Clin Nutr Metab Care. 2008. PMID: 18685455 Review.
-
Systemic nitric oxide production rate during hemodialysis and its relationship with nitric oxide-related factors.Blood Purif. 2005;23(4):317-24. doi: 10.1159/000087769. Epub 2005 Aug 23. Blood Purif. 2005. PMID: 16118486
-
Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.J Affect Disord. 2004 Jun;80(2-3):249-56. doi: 10.1016/S0165-0327(03)00135-6. J Affect Disord. 2004. PMID: 15207938
Cited by
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors.Acta Biomed. 2018 Jun 7;89(2):203-208. doi: 10.23750/abm.v89i2.5335. Acta Biomed. 2018. PMID: 29957752 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources